Federal contract award
75N99023F00001
C100883 CLINICAL CENTER RADIO PHARMACY/BIOLOGICS RADIOLABELING FACILITY CONSTRUCTION SERVICES COR: ASHISH PANDIT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH A E CONSTRUCTION |
| NAICS | 236220 — Commercial and Institutional Building Construction |
| PSC | Y1JZ — CONSTRUCTION OF MISCELLANEOUS BUILDINGS |
| Parent award / vehicle | 75N99019D00014 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $29.8M |
| Current contract value | $29.8M |
| Potential contract value / ceiling | $29.8M |
| Start date | Sep 25, 2023 |
| Current end date | Jul 28, 2026 |
| Potential end date | Jul 28, 2026 |
| Latest award activity | Jul 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 13 of 13 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 8, 2026 | P00012 | $323.5K | C100883: UNILATERAL MODIFICATION P00012 - VARIOUS CHANGE NOTIFICATIONS (CNS) 162 AND 170-174. WITHOUT THESE CHANGES, THE PROJECT WILL NOT COMPLETE AND USABLE. |
| Jul 21, 2026 | P00011 | $583.2K | C100883: THE SUBJECT CONTRACT IS MODIFIED TO INCORPORATE MOD. P00011 TO VARIOUS CHANGE NOTIFICATION NUMBERS. WITHOUT THESE CHANGES, THE PROJECT WILL NOT COMPLETE AND USABLE. |
| May 28, 2026 | P00010 | $455.2K | C100883: THE SUBJECT CONTRACT IS MODIFIED TO INCORPORATE MOD. P00010 TO DEFINITIZE VARIOUS CHANGE NOTIFICATION NUMBERS IN MOD. P00008. WITHOUT THESE CHANGES, THE PROJECT WILL NOT COMPLETE AND USABLE. |
| Feb 23, 2026 | P00009 | $320.0K | C100883: THE SUBJECT CONTRACT IS MODIFIED TO INCORPORATE UNILATERAL MOD. P00009. THE PROCUREMENT IS ESSENTIAL & ALLOWED TO PROCEED AS CONSTRUCTION CHANGE ODER. THE PROJECT WOULDN'T BE COMPLETE & USABLE WITHOUT MOD. |
| Sep 29, 2025 | P00007 | $685.0K | C100883 MOD.IS TO INCORPORATED VARIOUS CHANGE NOTIFICATIONS. THE PROCUREMENT IS ESSENTIAL & ALLOWED TO PROCEED AS CONSTRUCTION CHANGE ODER. THE PROJECT WOULD NOT BE COMPLETE & USABLE WITHOUT THIS MOD. |
| Sep 29, 2025 | P00008 | $125.8K | C100883: THE SUBJECT CONTRACT IS MODIFIED TO INCORPORATE UNILATERAL MOD. P00008. THE PROCUREMENT IS ESSENTIAL & ALLOWED TO PROCEED AS CONSTRUCTION CHANGE ODER. THE PROJECT WOULDN'T BE COMPLETE & USABLE WITHOUT MOD. |
| Jul 16, 2025 | P00006 | $2.9M | THE MOD.IS TO DEFINITIZE MOD.3 & CN #019 ON MOD.4. THE CN IS TO INCLUDE TIME EXTENSION & COST OF "NO CRANE APPROACH". THE PROCUREMENT IS ESSENTIAL TO PROCUREMENT & ALLOWED TO PROCEED AS CONSTRUCTION CHANGE ODER. THE PROJECT WOUL |
| Jun 11, 2025 | P00005 | $104.7K | C100883 CLINICAL CENTER RADIO PHARMACY/BIOLOGICS RADIOLABELING FACILITY CONSTRUCTION SERVICES REMAINING BALANCE, WHICH PARTIAL AMOUNTS WERE PREVIOUSLY INCLUDED UNDER MOD #P00004 - CN#32,35-38,41,43,45,46 FULL AMOUNTS - CN#50-53,59,63,64,66,69,81,82 |
| Sep 27, 2024 | P00004 | $570.0K | C100883 CLINICAL CENTER RADIO PHARMACY/BIOLOGICS RADIOLABELING FACILITY CONSTRUCTION SERVICES - NTP/NTE FOR CN #19 NO CRANE APPROACH PARTIAL - NTP/NTE FOR CN #27-29, 32, 34-35, 37-38, TBD1, 36, 41-47, 49, TBD4 COR: JEANNE KEEGAN PO: SEAN ROWE |
| Sep 26, 2024 | P00003 | $998.0K | C100883 CLINICAL CENTER RADIO PHARMACY/BIOLOGICS RADIOLABELING FACILITY CONSTRUCTION SERVICES - CN #019 PARTIAL AGREEMENT FOR NO CRANE APPROACH COR: JEANNE KEEGAN PO: SEAN ROWE |
| Sep 25, 2024 | P00002 | $536.8K | C100883 CLINICAL CENTER RADIO PHARMACY/BIOLOGICS RADIOLABELING FACILITY CONSTRUCTION SERVICES - CN #001-005, #007-010, #012, #013A&B, #014, #017-018, #021, #023-025, #030-031, #040 COR: JEANNE KEEGAN PO: SEAN ROWE |
| Feb 22, 2024 | P00001 | $0 | C100883 CLINICAL CENTER RADIO PHARMACY/BIOLOGICS RADIOLABELING FACILITY CONSTRUCTION SERVICES COR: PRAVEEN AGARWAL PO: SCOTT HELGESON |
| Aug 25, 2023 | 0 | $22.6M | C100883 CLINICAL CENTER RADIO PHARMACY/BIOLOGICS RADIOLABELING FACILITY CONSTRUCTION SERVICES COR: ASHISH PANDIT |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.